Pheton Holdings Ltd - Class A
Research Pheton Holdings Ltd - Class A (ITOC) on Bullrun: market cap USD 3.89M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerITOC
- ExchangeNASDAQ
- CountryChina
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 3.89M
- Financial periodFY2025
- RevenueUSD 523.03K
- Revenue growth16.7%
- Net income-USD 5.10M
- Free cash flow-USD 3.24M
- Gross margin62.6%
Valuation Snapshot
latest market cap is USD 3.89M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 523.03K | -USD 5.10M | -USD 3.24M | 62.6% | -0.32 | USD 1.49M | USD 143.00K | USD 6.12M |
| FY2024 | USD 448.20K | -USD 660.59K | -USD 775.86K | 85.0% | -0.05 | USD 6.16M | USD 247.97K | USD 6.18M |
| FY2023 | USD 628.59K | -USD 241.22K | n/a | 74.9% | -0.02 | USD 217.89K | n/a | USD 306.27K |
| FY2022 | USD 679.78K | USD 83.98K | n/a | 82.1% | 0.01 | USD 72.29K | n/a | USD 556.32K |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 3.89M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 5.99M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 62.84M | n/a | n/a | n/a |
About Pheton Holdings Ltd - Class A
iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Pheton Holdings Ltd - Class A's market cap?
Pheton Holdings Ltd - Class A's market capitalization is USD 3.89M.
What does Pheton Holdings Ltd - Class A do?
iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors.